Atea Pharmaceuticals, Inc. - PE Ratio

The PE Ratio as of July 2026 (TTM) for Atea Pharmaceuticals, Inc. (AVIR) is -2.19

According to Atea Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.19. This represents a change of 19.37% compared to the average of -1.83 of the last 4 quarters.

Atea Pharmaceuticals, Inc. (AVIR) Historical PE Ratio (quarterly & annually)

How has AVIR PE Ratio performed in the past?

The mean historical PE Ratio of Atea Pharmaceuticals, Inc. over the last ten years is -68.43. The current -2.19 PE Ratio has changed 220.03% with respect to the historical average. Over the past ten years (40 quarters), AVIR's PE Ratio was at its highest in in the June 2021 quarter at 268.50. The PE Ratio was at its lowest in in the September 2019 quarter at -98.76.

Atea Pharmaceuticals, Inc. (AVIR) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Atea Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Atea Pharmaceuticals, Inc. (AVIR) Average PE Ratio

How has AVIR PE Ratio performed in the past?

The current PE Ratio of Atea Pharmaceuticals, Inc. (AVIR) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Atea Pharmaceuticals, Inc. (AVIR) PE Ratio vs. Peers

How is AVIR’s PE Ratio compared to its peers?

Atea Pharmaceuticals, Inc.’s PE Ratio is less than Voyager Therapeutics, Inc. (-1.52), less than Vanda Pharmaceuticals Inc. (-1.25), greater than Allogene Therapeutics, Inc. (-2.35), less than Entrada Therapeutics, Inc. (-1.64), greater than Pyxis Oncology, Inc. (-2.23), less than Humacyte, Inc. (-1.06), greater than Enanta Pharmaceuticals, Inc. (-4.54), greater than Achieve Life Sciences, Inc. (-5.51), less than Arcturus Therapeutics Holdings Inc. (-2.05),

Build a custom stock screener for Atea Pharmaceuticals, Inc. (AVIR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atea Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atea Pharmaceuticals, Inc. (AVIR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atea Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.